Enhanced basal autophagy supports ameloblastoma-derived cell survival and reactivation

Autor: Olajumoke Ajibola Effiom, Sunday O. Akintoye, Kathleen Boesze-Battaglia, Adetokunbo Babajide Olawuyi, G T Arotiba, Rachel C. Sharp, Anuradha Dhingra, Onatolu Odukoya
Rok vydání: 2019
Předmět:
Zdroj: Archives of Oral Biology. 98:61-67
ISSN: 0003-9969
Popis: OBJECTIVES: Ameloblastoma is an aggressive odontogenic jaw neoplasm. Its unlimited growth confers high potential for malignant transformation and recurrence. It is unclear why ameloblastoma is highly recurrent despite surgical resection with a wide margin of normal tissue. While canonical autophagy can be used to degrade and eliminate damaged cellular components, it is also a protective mechanism that provides energy and vital metabolites for cell survival. We used ameloblastoma-derived cells to test the hypothesis that autophagic processes play a role in survival and reactivation of ameloblastoma. METHODS: Primary epithelial (EP-AMCs) and mesenchymal (MS-AMCs) ameloblastoma-derived cells were established from tissue samples of solid multicystic ameloblastoma. Clonogenic capacity and basal autophagic capacity were assessed in ameloblastoma-derived cells relative to human odontoma-derived cells (HODCs) and maxilla-mesenchymal stem cells (MX-MSCs). Ability of ameloblastoma-derived cells to survive and form new ameloblastoma was assessed in mouse tumor xenografts. RESULTS: EP-AMCs were highly clonogenic (p < 0.0001) and demonstrated enhanced basal levels of autophagic proteins microtubule-associated protein 1-light chain 3 (LC3) (p
Databáze: OpenAIRE